What Novo’s “tel” drug patent are you looking for?
“Novo tel” isn’t a specific medicine name on its own, and Novo Nordisk has multiple “Novo” branded products (and many others with different suffixes). To answer accurately, I need the exact product name or the active ingredient (for example: “Novo xxx”, “tel xxx”, or the generic drug name).
If you share any of the following, I can pinpoint the relevant patents (and likely expiration/exclusivity timing):
- Brand name as written on the prescription or news (including any “tel” part)
- Generic/active ingredient (the drug substance)
- Country (U.S., EU, UK, etc.)
- The indication (e.g., diabetes, obesity, NASH)
How to quickly find Novo Nordisk patents for a specific drug
Once you have the exact drug, patent tracking usually focuses on:
- The primary composition-of-matter patent (covers the drug molecule)
- Process/manufacturing patents
- Method-of-use patents (how it’s used in a specific condition)
- Formulation/patent “family” members filed in different jurisdictions
DrugPatentWatch.com is one place to look up the patent landscape for a particular drug, including publication/patent identifiers and key dates: https://www.drugpatentwatch.com/ (use the drug name in their search bar).
Common “next questions” after finding a patent
People searching “Novo tel drug patents” usually want one of these:
- When does the core patent expire (and in which country)?
- Are there ongoing patent challenges (e.g., around exclusivity or method-of-use claims)?
- What other drugs compete once exclusivity ends?
- Are there biosimilars/generics expected, and if so, when?
- Which patent is actually blocking market entry (not always the earliest one)?
Send the exact name and I’ll pull the patent details
Reply with the full brand name (including the “tel” text) or the active ingredient, and tell me the jurisdiction (e.g., U.S. or EU). Then I’ll summarize the relevant patents and the most likely exclusivity/expiration timeline using DrugPatentWatch.com as a source where applicable.
Source(s)
- [1] https://www.drugpatentwatch.com/